Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 821 results for "drl"

Diwali cheer continues; Sensex rallies over 200 points

NEW DELHI: The S&P BSE Sensex rallied over 200 points in trade on Wednesday, led by gains in DRL, Hero MotoCorp, Tata Motors, Wipro & TCS just a day ahead of Diwali. Tracking the momentum, the 50-share Nifty index also managed to reclaim its ... Economic Times, 8 minutes ago
Business Standard

US Congress steps up pressure for action on Sun Pharma, DRL

The US legislature's probe into ''abnormal'' increases in drug prices by 14 pharmaceutical companies, including India's Fceutical Industries and Dr Reddy's Laboratories, has gone to the next level. Congress (the legislature) has written to US ...
 Business Standard India1 day ago DRL, Sun Pharma among 14 companies facing price probe in US  Times of India1 week ago DRL, Sun Pharma among 14 cos facing price probe in US  Times of India1 week ago DRL Sun Pharma among 14 cos facing price probe in US  Big News Network1 week ago

Novartis Drags DRL to Court over Gleevec

HYDERABAD: Basel-headquartered Novartis Pharmaceuticals Corporation and Novartis AG dragged city-based Dr Reddy's Laboratories Ltd (DRL) and its US subsidiary Dr Reddy's Laboratories Inc to the US court over alleged patent infringement. As per ...
 New Indian Express1 day ago DRL, Aurobindo Dragged to US Court Over Patents  New Indian Express4 weeks ago NOVARTIS : Drags drl to us court for patent violation  4 Traders1 month ago NOVARTIS DRAGS DRL TO US COURT FOR PATENT VIOLATION  Pharmacy Choice1 month ago

DRL donates Rs 2 crs to Hudhud cyclone relief fund

Details Category: Latest Updates Published on Monday, 20 October 2014 12:28 Dr Reddy's Laboratories (DRL) has donated Rs two crores to Hudhud cyclone relief fund in a bid to help restore the lives of the people affected by the cyclone ...
 Express Pharma1 day ago DRL sues ex-associate over non-compete deal  The Financial Chronicle1 week ago DR REDDY LABORATORIES : -gsk pack runs into rough weather, review likely  4 Traders1 month ago Dr Reddy's-GSK pact runs into rough weather, review likely  Financial Express1 month ago

Companies resort to Theory of Constraints to stay ahead in the game

At DRL, TOC has not only tightened the supply chain with a focus on better inventory management in the US and Russia, but also in finance and project management. Five years ago, Dr Reddy's Laboratories (DRL) was facing a difficult time in the US. It had a ...
 Economic Times5 days ago

US price hike probe: Sun Pharma, DRL, Cadila tank 2-5%

This probed seems to be triggered by National Community Pharmacists Association (NCPA) 2013 survey of drug prices. In 2014, the NCPA had written to the US Senate seeking investigation into large upswing in acquisition prices of generic medicines.
 Money Control1 week ago Will US price hike probe hit Sun Pharma, DRL, Cadila?  Money Control1 week ago DRL, Ranbaxy yet to reduce drug prices after July10 order, many other cos cut prices  PharmaBiz1 month ago


The US subsidiaries of Dr Reddy's Laboratories , Sun Pharmaceutical Industries and Cadila Healthcare are among the 14 companies that have received notices from a Senate Healthcare Subcommittee. The US Congress is investigating ...
 4 Traders1 week ago DRL, Sun and Cadila arms under US lens for 'soaring' prices  Financial Express1 week ago

Sensex, Nifty weak; BHEL, Infosys, DRL, Hero shine

Along with Infosys (that maintained 6 percent gain from early trade on strong Q2 earnings), BHEL, Dr Reddy's Labs, Hero Motocorp, Sun Pharma, Asian Paints and HCL Technologies outperformed the market, up 1-2.5 percent.
 Money Control1 week ago

Sensex rangebound; Infosys, Sun Pharma, TCS and DRL top losers

MUMBAI: The S&P BSE Sensex managed to recoup losses after falling 84 points in trade on Wednesday, led by losses in Infosys, Sun Pharma, TCS and DRL. "FII's selling continues even as investors look forward to the earnings season. The global cues ...
 Economic Times1 week ago

DRL launches Levalbuterol inhalation solution in the US

Gets approval from US FDA Dr Reddy's Laboratories (DRL) has launched Levalbuterol inhalation solution, USP 0.31 mg /3 mL, 0.63 mg /3 mL, 1.25 mg / 3 mL Unit-Dose Vials, a therapeutic equivalent generic version of Xopenex (levalbuterol ...
 Express Pharma3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less